Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.
about
Cellular immunotherapy of cancer: an overview and future directions.Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.Cancer treatment and the KIR-HLA system: an overview.Immune correlates of clinical outcome in melanoma.The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
P2860
Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@en
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@nl
type
label
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@en
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@nl
prefLabel
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@en
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@nl
P2093
P2860
P1476
Frequent HLA class I alteratio ...... anisms and clinical relevance.
@en
P2093
Ana Belen Del Campo
Cesar García-Lopez
Federico Garrido
Francisco Javier Carretero
Francisco Ruiz-Cabello
Jose Francisco Flores-Martín
Jose Manuel Cozar
Natalia Aptsiauri
Rosa Mendez
Stephen Ward
P2860
P2888
P356
10.1007/S00262-015-1774-5
P577
2015-11-26T00:00:00Z